Armata Pharmaceuticals Inc (ARMP)
NYSE MKT:ARMP
Holding ARMP?
Track your performance easily

Armata Pharmaceuticals (ARMP) Financial Statements

252 Followers

Armata Pharmaceuticals Financial Overview

Armata Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.353; its P/E ratio is -0.95; Armata Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 966.00K$ 3.73M-$ 980.00K
Gross Profit-$ 966.00K$ 1.53M$ 1.23M$ 980.00K
EBIT$ 11.70M$ -23.20M-$ -29.98M$ -3.55M
EBITDA$ 12.02M$ -22.88M-$ -29.76M$ -3.32M
Net Income Common Stockholders$ 8.99M$ -25.02M$ -19.85M$ -31.16M$ -3.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 26.40M$ 37.90M$ 13.50M$ 24.00M$ 12.50M
Total Assets$ 108.31M$ 120.36M$ 98.36M$ 112.76M$ 101.26M
Total Debt$ 146.14M$ 167.91M$ 120.37M$ 113.63M$ 68.31M
Net Debt$ 119.74M$ 130.01M$ 106.87M$ 89.63M$ 55.81M
Total Liabilities$ 154.41M$ 176.87M$ 130.43M$ 125.15M$ 82.07M
Stockholders Equity$ -46.10M$ -56.51M$ -32.06M$ -12.39M$ 19.14M
Cash Flow-
Free Cash Flow$ -11.54M$ -10.83M$ -10.50M$ -13.20M$ -12.28M
Operating Cash Flow$ -10.18M$ -10.58M$ -8.11M$ -9.69M$ -12.06M
Investing Cash Flow$ -1.37M$ -250.00K$ -2.39M$ -3.51M$ -222.00K
Financing Cash Flow$ 88.00K$ 34.93M$ -43.00K$ 24.80M$ -368.00K
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

Armata Pharmaceuticals Debt to Assets

Armata Pharmaceuticals Cash Flow

Armata Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis